Etomidate: Use, Risks, and Safety Considerations

Naomi Carr
Dr. Jennie Stanford
Written by Naomi Carr on 09 October 2025
Medically reviewed by Dr. Jennie Stanford on 17 October 2025

Etomidate is a sedative-hypnotic used medically to induce unconsciousness for medical anesthesia. Etomidate is also increasingly being used in e-cigarette or vaping devices, particularly in areas of Southeast Asia such as Singapore. This use of etomidate outside of medical indications is illegal and unregulated and can have severe or life-threatening consequences.

Key takeaways:
  • Etomidate is a medication used as an anesthetic agent with fast and short-lived sedating effects.
  • Etomidate is also being used illicitly in vaping products, which can cause severe adverse effects.
  • Etomidate abuse can lead to dependence and addiction and may require professional treatment.
a close up photo of a pair of gloved hands holding a syringe full of etomidate

What is etomidate?

Etomidate is an intravenous anesthetic. It is approved for use in clinical settings and is only administered intravenously. Etomidate is used for short medical procedures, such as reducing dislocated joints, curettage, and tracheal intubation, as the effects emerge very quickly and last a short time.

After administration, effects begin to emerge within one minute, causing the individual to become unconscious in preparation for medical anesthesia. The effects of one dose last for around three to five minutes. Etomidate impacts GABA receptors, creating its sedating effects.

Etomidate has similar or greater sedative effects than alternatives (such as propofol), and in some cases, it can be preferable, as it causes less impact on cardiac function. However, it can be dangerous when it is used continuously during longer periods of anesthesia and can cause impaired organ functioning.

Etomidate dosage and administration

Etomidate is used as a sedative hypnotic agent, typically as a part of a sequence to induce anesthesia. Generally, it is administered at a dose of 0.3 mg per kg of body weight, although this can range from 0.2-0.6 mg/kg. It is injected into the vein over a period of 30 to 60 seconds, and it should only be administered by a professional with appropriate training in the administration of general anesthetics.

Doses may need to be reduced for children or geriatric patients. Etomidate should not be given to people younger than 10 years old.

Side effects & managing adverse events

Side effects of etomidate used within clinical settings can include:

  • Pain on injection
  • Adrenocortical depression
  • Post-operative nausea or vomiting
  • Muscle spasms
  • Involuntary movements

In some cases, side effects can occur that affect breathing or heart function. However, because etomidate is administered only in a surgical setting, these side effects can be effectively managed by professionals.

Drug interactions

Etomidate is a sedative, causing central nervous system (CNS) depression. Because of this, using etomidate with other CNS depressant substances, whether in a clinical setting or as a recreational drug, can increase the risk of severe sedation, respiratory depression, and even death. This can include substances such as alcohol, benzodiazepines, and opioids.

Emerging patterns of misuse in vapes

Reports of etomidate misuse are increasing in several countries worldwide, but particularly in East and Southeast Asia, where it is being sold in cartridges to be used in e-vaporizers. In Singapore, for example, etomidate-laced cartridges are sold online and referred to as Kpods.

This use of etomidate has been reported to lead to severe adverse effects, including neuropsychiatric and physiological effects:

  • Agitation
  • Mood swings
  • Aggression
  • Suicidal behavior
  • Psychosis
  • Drowsiness
  • Confusion
  • Weakness
  • Shaking
  • Involuntary movements
  • Adrenal dysfunction
  • Changes in blood pressure
  • Cardiac arrhythmias

It has also been found to lead to cases of addiction, dependence, withdrawal, toxicity, and overdose.

Risks of unregulated etomidate vapes

Using etomidate vapes is particularly dangerous because these products are unregulated. As such, their content and potency can vary significantly between products, and people may be unaware of the dosage being used or if the product is safe to use.

Furthermore, vaping poses particular risks, as users may easily lose track of how much they have smoked or might use the product consistently over several hours or days, potentially leading to toxicity and unpredictable effects.

Etomidate dependence and withdrawal

Currently, research into the effects of etomidate as a recreational drug related to the development of dependence and addiction is limited. However, there are some reports about individual use of etomidate e-cigarettes that detail steadily increasing use and withdrawal symptoms upon cessation, suggesting it carries a risk of tolerance, dependence, and addiction development.

One report includes a female patient who abruptly stopped excessive etomidate vaping, which led to severe mood swings, suicidal ideation, hallucinations, and anxiety. She was admitted to the hospital, where she received detoxification treatment and symptom management.

Etomidate toxicity and overdose

Etomidate use in vapes has been found to be associated with several cases of severe toxicity and overdose, resulting in:

  • Dangerously low blood potassium levels (hypokalemia)
  • Adrenal insufficiency and dysfunction
  • Extreme weakness in muscles and limbs
  • Loss of consciousness and coma
  • Seizures
  • Severe agitation and aggression
  • Psychotic symptoms
  • Cardiac arrhythmias
  • Death

Etomidate abuse with vapes is mostly affecting East and Southeast Asian countries, including Hong Kong and Singapore. In Singapore, the Health Minister Ong Ye Kung announced in July 2025 that etomidate will be reclassified under the Misuse of Drugs Act (MDA). Previously, etomidate was included in the Poisons Act, which states that it can only be used by licensed professionals, and the possession, use, or sale of etomidate is illegal with significant fines and prison time.

In Hong Kong, etomidate was regulated under the Pharmacy and Poisons Regulations, which means possession of etomidate can be punished with fines and prison sentences. It was reclassified in February 2025 as a controlled drug under the Dangerous Drugs Ordinance.

These new classifications mean that offences involving etomidate, including possession, use, or trafficking of etomidate, can incur much heavier fines and sentences. Illicit etomidate use is also reportedly increasing in other countries, including the US and UK, where it is being found in the drug supply, often mixed with fentanyl or other substances.

Seeking help: Harm reduction & treatment

Using etomidate as a recreational drug, such as smoking in vapes, can lead to severe risks and harm. Trying to stop etomidate use can be difficult without professional support, as this can cause dangerous withdrawal symptoms. People who wish to manage etomidate use without professional support may benefit from gradually reducing their use, rather than abruptly stopping.

People can consult with their primary care physician for advice about available treatment options and specialist services. Substance use disorder treatments can help with supportive care of withdrawal, via inpatient or outpatient services, and medicinal and therapeutic interventions to support recovery.

FAQs

Common questions about etomidate

Is etomidate still being used today?

Yes, etomidate continues to be used as an anesthetic agent for short procedures. However, there is much debate around the safety of etomidate as a continuous anesthetic agent for longer procedures and when compared to alternatives. As such, it is typically only used in patients with hemodynamic instability.

Is etomidate the same as propofol? Which one is better?

Propofol is also an anesthetic with a fast and short-lived action. Etomidate and propofol vary in their effects on organ functioning. However, the use of propofol is regulated, adding to its safety.

Can you quit etomidate cold turkey?

Abruptly stopping etomidate use (cold turkey) can result in severe withdrawal symptoms. Tapering or supported withdrawal may be necessary.

Is etomidate addictive?

Yes, etomidate use can lead to addiction, particularly if it is misused for a prolonged period.

Was this page helpful?

Your feedback allows us to continually improve our information

Resources:

  1. Valk, B. I., & Struys, M. M. R. F. (2021). Etomidate and its Analogs: A Review of Pharmacokinetics and Pharmacodynamics. Clinical pharmacokinetics, 60(10), 1253–1269.
  2. Hospira, Inc. (Revised 2017). Amidate (Etomidate) Injection. FDA. Retrieved August 17, 2025 from
  3. Uhm, J., Hong, S., & Han, E. (2024). The Need to Monitor Emerging Issues in Etomidate Usage: The Misuse or Abuse Potential. Forensic Science, Medicine, and Pathology20(1), 249–260.
  4. United Nations Office on Drugs and Crime. (2025). Increasing Detections of Etomidate and Analogues Becoming a Global Concern. UNODC. Retrieved from
  5. Wu, W., Xia, C., Gan, L., Liao, S., & Yan, Y. (2024). Etomidate-Induced Hypokalemia in Electronic Cigarette Users: Two Case Reports and Literature Review. Frontiers in Endocrinology15, 1321610.
  6. Ng, C.Z., Hamood Said Al-Aamari, H., Low, L.T.K., & Zhang, M.W. (2025). The Emerging Landscape of Etomidate E-Cigarettes Use. Addiction (Abingdon, England), 10.1111/add.70151. Advance online publication. Retrieved August 17, 2025 from
  7. Lin, C.H., & Lin, C.H. (2024). From Benzodiazepine to Etomidate: A Risky Novel Psychoactive Substance. Indian Journal of Psychiatry66(10), 981–982.
  8. Lee, J. (2025). What Does it Mean for Etomidate to be Listed Under the Misuse of Drugs Act? The Straits Times. Retrieved August 17, 2025 from
  9. The Government of Hong Kong. (2025). Combating Vaping of “Space Oil”. Gov HK. Retrieved August 17, 2025 from
  10. De Jong, A., & Jaber, S. (2014). Etomidate for Anesthesia Induction: Friend or Foe in Major Cardiac Surgery? Critical Care (London, England)18(5), 560.

Activity History - Last updated: 17 October 2025, Published date:


Reviewer

Dr. Jennie Stanford

MD, FAAFP, DipABOM

Jennie Stanford, MD, FAAFP, DipABOM is a dual board-certified physician in both family medicine and obesity medicine. She has a wide range of clinical experiences, ranging from years of traditional clinic practice to hospitalist care to performing peer quality review to ensure optimal patient care.

Activity History - Medically Reviewed on 08 October 2025 and last checked on 17 October 2025

Medically reviewed by
Dr. Jennie Stanford

Dr. Jennie Stanford

MD, FAAFP, DipABOM

Reviewer

Recovered Branding BG
Ready to talk about treatment? Call today. (833) 840-1202
Helpline Information

Calls to numbers marked with (I) symbols will be answered or returned by one of the treatment providers listed in our Terms and Conditions, each of which is a paid advertiser.

In calling the helpline you agree to our Terms and Conditions. We do not receive any fee or commission dependent upon which treatment or provider a caller chooses.

There is no obligation to enter treatment.

Access State-Specific Provider Directories for detailed information on locating licensed service providers and recovery residences in your area.

For any specific questions please email us at info@recovered.org

More like this